0 XP   0   0   0

Core Laboratories NV
Buy, Hold or Sell?

Let's analyse Core Laboratories NV together

PenkeI guess you are interested in Core Laboratories NV. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Core Laboratories NV. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Core Laboratories NV

I send you an email if I find something interesting about Core Laboratories NV.

Quick analysis of Core Laboratories NV (30 sec.)










1. Valuation of Core Laboratories NV (5 min.)




Current price per share

€21.00

2. Growth of Core Laboratories NV (5 min.)




Is Core Laboratories NV growing?

Current yearPrevious yearGrowGrow %
How rich?$160.9m$75.5m$85.3m53.1%

How much money is Core Laboratories NV making?

Current yearPrevious yearGrowGrow %
Making money$19.7m-$97.5m$117.3m594.9%
Net Profit Margin4.2%-20.0%--

How much money comes from the company's main activities?

3. Financial Health of Core Laboratories NV (5 min.)




4. Comparing to competitors in the Oil & Gas Equipment & Services industry (5 min.)




  Industry Rankings (Oil & Gas Equipment & Services)  


Richest
#84 / 190

Most Revenue
#85 / 190

Most Profit
#62 / 190


Fundamentals of Core Laboratories NV

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

1.1. Profitability of Core Laboratories NV.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Core Laboratories NV earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Core Laboratories NV to the Oil & Gas Equipment & Services industry mean.
  • A Net Profit Margin of 4.2% means that €0.04 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Core Laboratories NV:

  • The MRQ is 4.2%. The company is making a profit. +1
  • The TTM is 4.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.2%TTM4.2%0.0%
TTM4.2%YOY-20.0%+24.2%
TTM4.2%5Y4.7%-0.5%
5Y4.7%10Y9.1%-4.3%
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2%2.1%+2.1%
TTM4.2%1.8%+2.4%
YOY-20.0%-1.6%-18.4%
5Y4.7%-6.4%+11.1%
10Y9.1%-3.9%+13.0%
1.1.2. Return on Assets

Shows how efficient Core Laboratories NV is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Core Laboratories NV to the Oil & Gas Equipment & Services industry mean.
  • 3.4% Return on Assets means that Core Laboratories NV generated €0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Core Laboratories NV:

  • The MRQ is 3.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.4%TTM3.4%0.0%
TTM3.4%YOY-17.2%+20.6%
TTM3.4%5Y5.2%-1.8%
5Y5.2%10Y11.7%-6.5%
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4%0.6%+2.8%
TTM3.4%0.4%+3.0%
YOY-17.2%-0.3%-16.9%
5Y5.2%-1.0%+6.2%
10Y11.7%-0.5%+12.2%
1.1.3. Return on Equity

Shows how efficient Core Laboratories NV is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Core Laboratories NV to the Oil & Gas Equipment & Services industry mean.
  • 12.3% Return on Equity means Core Laboratories NV generated €0.12 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Core Laboratories NV:

  • The MRQ is 12.3%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 12.3%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ12.3%TTM12.3%0.0%
TTM12.3%YOY-129.2%+141.4%
TTM12.3%5Y9.7%+2.5%
5Y9.7%10Y48.1%-38.4%
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ12.3%1.4%+10.9%
TTM12.3%1.2%+11.1%
YOY-129.2%-0.4%-128.8%
5Y9.7%-2.2%+11.9%
10Y48.1%-1.2%+49.3%

1.2. Operating Efficiency of Core Laboratories NV.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Core Laboratories NV is operating .

  • Measures how much profit Core Laboratories NV makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Core Laboratories NV to the Oil & Gas Equipment & Services industry mean.
  • An Operating Margin of 8.8% means the company generated €0.09  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Core Laboratories NV:

  • The MRQ is 8.8%. The company is operating less efficient.
  • The TTM is 8.8%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ8.8%TTM8.8%0.0%
TTM8.8%YOY10.2%-1.4%
TTM8.8%5Y13.7%-4.9%
5Y13.7%10Y17.9%-4.2%
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ8.8%5.0%+3.8%
TTM8.8%3.7%+5.1%
YOY10.2%0.4%+9.8%
5Y13.7%-2.6%+16.3%
10Y17.9%-1.0%+18.9%
1.2.2. Operating Ratio

Measures how efficient Core Laboratories NV is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Oil & Gas Equipment & Services industry mean).
  • An Operation Ratio of 1.74 means that the operating costs are €1.74 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Core Laboratories NV:

  • The MRQ is 1.737. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.737. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.737TTM1.7370.000
TTM1.737YOY1.697+0.040
TTM1.7375Y1.625+0.112
5Y1.62510Y1.557+0.069
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7371.529+0.208
TTM1.7371.460+0.277
YOY1.6971.468+0.229
5Y1.6251.320+0.305
10Y1.5571.175+0.382

1.3. Liquidity of Core Laboratories NV.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Core Laboratories NV is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Oil & Gas Equipment & Services industry mean).
  • A Current Ratio of 2.08 means the company has €2.08 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Core Laboratories NV:

  • The MRQ is 2.083. The company is able to pay all its short-term debts. +1
  • The TTM is 2.083. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.083TTM2.0830.000
TTM2.083YOY1.848+0.235
TTM2.0835Y2.046+0.037
5Y2.04610Y2.036+0.010
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0831.484+0.599
TTM2.0831.570+0.513
YOY1.8481.609+0.239
5Y2.0461.739+0.307
10Y2.0361.757+0.279
1.3.2. Quick Ratio

Measures if Core Laboratories NV is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Core Laboratories NV to the Oil & Gas Equipment & Services industry mean.
  • A Quick Ratio of 1.18 means the company can pay off €1.18 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Core Laboratories NV:

  • The MRQ is 1.176. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.176. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.176TTM1.1760.000
TTM1.176YOY1.035+0.141
TTM1.1765Y1.323-0.147
5Y1.32310Y1.361-0.038
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1760.862+0.314
TTM1.1760.904+0.272
YOY1.0351.021+0.014
5Y1.3231.065+0.258
10Y1.3611.105+0.256

1.4. Solvency of Core Laboratories NV.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Core Laboratories NV assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Core Laboratories NV to Oil & Gas Equipment & Services industry mean.
  • A Debt to Asset Ratio of 0.72 means that Core Laboratories NV assets are financed with 72.3% credit (debt) and the remaining percentage (100% - 72.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Core Laboratories NV:

  • The MRQ is 0.723. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.723. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.723TTM0.7230.000
TTM0.723YOY0.867-0.144
TTM0.7235Y0.774-0.051
5Y0.77410Y0.814-0.040
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7230.509+0.214
TTM0.7230.523+0.200
YOY0.8670.526+0.341
5Y0.7740.502+0.272
10Y0.8140.489+0.325
1.4.2. Debt to Equity Ratio

Measures if Core Laboratories NV is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Core Laboratories NV to the Oil & Gas Equipment & Services industry mean.
  • A Debt to Equity ratio of 260.8% means that company has €2.61 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Core Laboratories NV:

  • The MRQ is 2.608. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.608. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ2.608TTM2.6080.000
TTM2.608YOY6.524-3.916
TTM2.6085Y3.733-1.125
5Y3.73310Y3.508+0.225
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6080.981+1.627
TTM2.6080.959+1.649
YOY6.5241.051+5.473
5Y3.7331.026+2.707
10Y3.5081.028+2.480

2. Market Valuation of Core Laboratories NV

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Core Laboratories NV generates.

  • Above 15 is considered overpriced but always compare Core Laboratories NV to the Oil & Gas Equipment & Services industry mean.
  • A PE ratio of 51.37 means the investor is paying €51.37 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Core Laboratories NV:

  • The EOD is 53.142. Good. +1
  • The MRQ is 51.371. Good. +1
  • The TTM is 51.371. Good. +1
Trends
Current periodCompared to+/- 
EOD53.142MRQ51.371+1.771
MRQ51.371TTM51.3710.000
TTM51.371YOY-10.942+62.312
TTM51.3715Y28.211+23.160
5Y28.21110Y25.427+2.783
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
EOD53.1429.480+43.662
MRQ51.37110.680+40.691
TTM51.3716.329+45.042
YOY-10.942-0.547-10.395
5Y28.2116.417+21.794
10Y25.42715.276+10.151
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Core Laboratories NV.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Core Laboratories NV:

  • The MRQ is 23.329. Seems overpriced? -1
  • The TTM is 23.329. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ23.329TTM23.3290.000
TTM23.329YOY11.429+11.900
TTM23.3295Y24.246-0.917
5Y24.24610Y35.830-11.584
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ23.32913.658+9.671
TTM23.32917.121+6.208
YOY11.4293.185+8.244
5Y24.24647.207-22.961
10Y35.830126.360-90.530

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Core Laboratories NV is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Oil & Gas Equipment & Services industry mean).
  • A PB ratio of 6.29 means the investor is paying €6.29 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Core Laboratories NV:

  • The EOD is 6.511. Seems overpriced? -1
  • The MRQ is 6.294. Seems overpriced? -1
  • The TTM is 6.294. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD6.511MRQ6.294+0.217
MRQ6.294TTM6.2940.000
TTM6.294YOY14.136-7.842
TTM6.2945Y15.203-8.909
5Y15.20310Y-4.115+19.318
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
EOD6.5111.100+5.411
MRQ6.2941.181+5.113
TTM6.2941.260+5.034
YOY14.1361.143+12.993
5Y15.2031.115+14.088
10Y-4.1151.407-5.522
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Core Laboratories NV compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.7111.7110%-2.049+220%0.039+4328%0.403+324%
Book Value Growth--2.1302.1300%0.425+401%1.146+86%1.804+18%
Book Value Per Share--3.2253.2250%1.514+113%2.869+12%2.335+38%
Book Value Per Share Growth--2.1302.1300%0.425+401%1.146+86%1.804+18%
Current Ratio--2.0832.0830%1.848+13%2.046+2%2.036+2%
Debt To Asset Ratio--0.7230.7230%0.867-17%0.774-7%0.814-11%
Debt To Equity Ratio--2.6082.6080%6.524-60%3.733-30%3.508-26%
Dividend Per Share--0.0370.0370%0.249-85%1.227-97%1.464-97%
Dividend Per Share Growth--0.1470.1470%0.128+16%0.660-78%0.767-81%
Eps--0.3950.3950%-1.956+595%0.748-47%1.560-75%
Eps Growth--2.2022.2020%-0.957+143%0.957+130%0.872+153%
Free Cash Flow Per Share--0.4620.4620%0.911-49%1.321-65%2.282-80%
Free Cash Flow Per Share Growth--0.5060.5060%0.678-25%0.732-31%0.715-29%
Free Cash Flow To Equity Per Share--0.0120.0120%-0.351+3115%0.047-75%0.063-82%
Free Cash Flow To Equity Per Share Growth--2.0332.0330%1.068+90%9.920-80%7.594-73%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---11.993--------
Intrinsic Value_10Y_min---9.589--------
Intrinsic Value_1Y_max--0.452--------
Intrinsic Value_1Y_min--0.439--------
Intrinsic Value_3Y_max--0.098--------
Intrinsic Value_3Y_min--0.115--------
Intrinsic Value_5Y_max---1.776--------
Intrinsic Value_5Y_min---1.527--------
Net Profit Margin--0.0420.0420%-0.200+578%0.047-11%0.091-54%
Operating Margin--0.0880.0880%0.102-14%0.137-36%0.179-51%
Operating Ratio--1.7371.7370%1.697+2%1.625+7%1.557+12%
Pb Ratio6.511+3%6.2946.2940%14.136-55%15.203-59%-4.115+165%
Pe Ratio53.142+3%51.37151.3710%-10.942+121%28.211+82%25.427+102%
Peg Ratio--23.32923.3290%11.429+104%24.246-4%35.830-35%
Price Per Share21.000+3%20.30020.3000%21.400-5%42.642-52%51.926-61%
Price To Total Gains Ratio12.014+3%11.61311.6130%-11.890+202%16.990-32%-7.539+165%
Profit Growth--2.2022.2020%-0.957+143%0.957+130%0.827+166%
Quick Ratio--1.1761.1760%1.035+14%1.323-11%1.361-14%
Return On Assets--0.0340.0340%-0.172+606%0.052-34%0.117-71%
Return On Equity--0.1230.1230%-1.292+1154%0.097+26%0.481-75%
Revenue Growth--0.9650.9650%0.729+32%0.9650%0.900+7%
Total Gains Per Share--1.7481.7480%-1.800+203%1.266+38%1.867-6%
Total Gains Per Share Growth--2.9712.9710%-0.757+125%0.967+207%2.320+28%
Usd Book Value--160934875.279160934875.2790%75541961.413+113%143149582.878+12%116492760.600+38%
Usd Book Value Change Per Share--1.8421.8420%-2.205+220%0.042+4328%0.434+324%
Usd Book Value Per Share--3.4713.4710%1.629+113%3.087+12%2.512+38%
Usd Dividend Per Share--0.0400.0400%0.268-85%1.320-97%1.576-97%
Usd Eps--0.4250.4250%-2.105+595%0.805-47%1.679-75%
Usd Free Cash Flow--23030537.24223030537.2420%45471316.802-49%65897124.272-65%113891954.216-80%
Usd Free Cash Flow Per Share--0.4970.4970%0.981-49%1.421-65%2.456-80%
Usd Free Cash Flow To Equity Per Share--0.0130.0130%-0.378+3115%0.051-75%0.068-82%
Usd Price Per Share22.598+3%21.84521.8450%23.029-5%45.887-52%55.878-61%
Usd Profit--19718897.92419718897.9240%-97596899.508+595%37329462.117-47%77836893.474-75%
Usd Revenue--470058862.801470058862.8010%487066874.570-3%594634477.328-21%680641338.936-31%
Usd Total Gains Per Share--1.8811.8810%-1.937+203%1.362+38%2.009-6%
 EOD+2 -3MRQTTM+0 -0YOY+30 -125Y+19 -2310Y+17 -25

3.2. Fundamental Score

Let's check the fundamental score of Core Laboratories NV based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1553.142
Price to Book Ratio (EOD)Between0-16.511
Net Profit Margin (MRQ)Greater than00.042
Operating Margin (MRQ)Greater than00.088
Quick Ratio (MRQ)Greater than11.176
Current Ratio (MRQ)Greater than12.083
Debt to Asset Ratio (MRQ)Less than10.723
Debt to Equity Ratio (MRQ)Less than12.608
Return on Equity (MRQ)Greater than0.150.123
Return on Assets (MRQ)Greater than0.050.034
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Core Laboratories NV based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.173
Ma 20Greater thanMa 5020.725
Ma 50Greater thanMa 10018.787
Ma 100Greater thanMa 20017.807
OpenGreater thanClose20.500
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2017-12-312018-12-312019-12-312020-12-312021-12-31
Net Tangible Assets  -40,496-29,828-70,32421,083-49,24115,322-33,91979,30945,391
Minority Interest  3,6122353,8471243,971-2003,771-4,228-457



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets580,853
Total Liabilities419,852
Total Stockholder Equity161,001
 As reported
Total Liabilities 419,852
Total Stockholder Equity+ 161,001
Total Assets = 580,853

Assets

Total Assets580,853
Total Current Assets189,055
Long-term Assets189,055
Total Current Assets
Cash And Cash Equivalents 17,703
Net Receivables 106,741
Inventory 45,443
Other Current Assets 5,109
Total Current Assets  (as reported)189,055
Total Current Assets  (calculated)174,996
+/- 14,059
Long-term Assets
Property Plant Equipment 172,339
Goodwill 99,445
Long Term Investments 4,156
Intangible Assets 8,139
Other Assets 107,719
Long-term Assets  (as reported)391,798
Long-term Assets  (calculated)391,798
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities90,782
Long-term Liabilities329,070
Total Stockholder Equity161,001
Total Current Liabilities
Accounts payable 29,726
Other Current Liabilities 21,950
Total Current Liabilities  (as reported)90,782
Total Current Liabilities  (calculated)51,676
+/- 39,106
Long-term Liabilities
Long term Debt 188,636
Capital Lease Obligations Min Short Term Debt61,628
Other Liabilities 85,702
Long-term Liabilities Other 91,148
Long-term Liabilities  (as reported)329,070
Long-term Liabilities  (calculated)427,114
+/- 98,044
Total Stockholder Equity
Common Stock1,188
Retained Earnings 68,349
Total Stockholder Equity (as reported)161,001
Total Stockholder Equity (calculated)69,537
+/- 91,464
Other
Capital Stock1,188
Common Stock Shares Outstanding 46,290
Net Debt 170,933
Net Invested Capital 188,636
Net Tangible Assets 48,865
Net Working Capital 98,273



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
> Total Assets 
673,325
625,258
573,052
584,812
648,827
774,673
568,579
580,853
580,853568,579774,673648,827584,812573,052625,258673,325
   > Total Current Assets 
301,820
238,547
186,461
207,427
230,977
221,237
165,848
189,055
189,055165,848221,237230,977207,427186,461238,547301,820
       Cash And Cash Equivalents 
23,350
22,494
14,764
14,400
13,116
11,092
13,806
17,703
17,70313,80611,09213,11614,40014,76422,49423,350
       Net Receivables 
208,143
145,689
120,755
140,605
143,150
138,106
92,867
106,741
106,74192,867138,106143,150140,605120,755145,689208,143
       Inventory 
43,371
40,906
33,720
33,317
45,664
50,163
38,151
45,443
45,44338,15150,16345,66433,31733,72040,90643,371
       Other Current Assets 
12,710
10,196
6,511
6,513
13,696
5,925
6,227
5,109
5,1096,2275,92513,6966,5136,51110,19612,710
   > Long-term Assets 
0
0
386,591
377,385
417,850
553,436
402,731
391,798
391,798402,731553,436417,850377,385386,59100
       Property Plant Equipment 
149,014
143,211
129,882
123,098
122,917
199,203
181,678
172,339
172,339181,678199,203122,917123,098129,882143,211149,014
       Goodwill 
164,464
178,159
179,044
179,044
219,412
213,425
99,445
99,445
99,44599,445213,425219,412179,044179,044178,159164,464
       Long Term Investments 
2,336
2,719
3,224
3,557
3,760
3,969
4,094
4,156
4,1564,0943,9693,7603,5573,2242,7192,336
       Intangible Assets 
10,642
10,041
9,936
9,396
13,054
17,450
8,583
8,139
8,1398,58317,45013,0549,3969,93610,04110,642
       Long-term Assets Other 
0
0
43,900
51,571
47,455
52,077
36,156
37,257
37,25736,15652,07747,45551,57143,90000
> Total Liabilities 
579,332
654,322
421,698
439,968
492,068
596,808
493,006
419,852
419,852493,006596,808492,068439,968421,698654,322579,332
   > Total Current Liabilities 
131,866
120,758
104,023
100,576
102,547
111,594
89,750
90,782
90,78289,750111,594102,547100,576104,023120,758131,866
       Short-term Debt 
354,754
432,569
217,534
227,411
0
0
0
0
0000227,411217,534432,569354,754
       Short Long Term Debt 
354,754
432,569
217,534
227,411
0
0
0
0
0000227,411217,534432,569354,754
       Accounts payable 
47,084
33,474
33,720
41,697
41,155
35,611
23,028
29,726
29,72623,02835,61141,15541,69733,72033,47447,084
       Other Current Liabilities 
38,966
41,314
45,076
22,679
31,355
29,087
22,203
21,950
21,95022,20329,08731,35522,67945,07641,31438,966
   > Long-term Liabilities 
0
0
313,732
331,062
385,380
480,939
403,256
329,070
329,070403,256480,939385,380331,062313,73200
       Long term Debt Total 
0
430,987
216,488
226,989
289,770
305,283
0
0
00305,283289,770226,989216,488430,9870
       Capital Lease Obligations 
0
0
0
0
0
76,501
67,545
61,628
61,62867,54576,50100000
       Long-term Liabilities Other 
0
0
44,716
45,964
37,216
33,173
87,715
91,148
91,14887,71533,17337,21645,96444,71600
       Deferred Long Term Liability 
0
48,359
52,528
58,109
0
0
0
0
000058,10952,52848,3590
> Total Stockholder Equity
87,573
-29,064
151,354
144,844
156,759
177,865
75,573
161,001
161,00175,573177,865156,759144,844151,354-29,06487,573
   Common Stock
1,174
1,142
1,148
1,148
1,148
1,148
1,148
1,188
1,1881,1481,1481,1481,1481,1481,1421,174
   Retained Earnings Total Equity00000000
   Accumulated Other Comprehensive Income 00000000
   Capital Surplus 
0
0
52,850
54,463
57,438
51,872
0
0
0051,87257,43854,46352,85000
   Treasury Stock00-29,364-52,501-76,269-80,773-238,8750
   Other Stockholders Equity -10,133-7,200-6,330-5,456-8,353-9,828-337-11,894



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue470,252
Cost of Revenue-386,412
Gross Profit83,84083,840
 
Operating Income (+$)
Gross Profit83,840
Operating Expense-430,585
Operating Income39,667-346,745
 
Operating Expense (+$)
Research Development-
Selling General Administrative44,173
Selling And Marketing Expenses-
Operating Expense430,58544,173
 
Net Interest Income (+$)
Interest Income-
Interest Expense-9,152
Other Finance Cost-0
Net Interest Income-9,152
 
Pretax Income (+$)
Operating Income39,667
Net Interest Income-9,152
Other Non-Operating Income Expenses-
Income Before Tax (EBT)36,11034,072
EBIT - interestExpense = 32,145
35,618
28,879
Interest Expense9,152
Earnings Before Interest and Taxes (EBIT)41,29745,262
Earnings Before Interest and Taxes (EBITDA)63,778
 
After tax Income (+$)
Income Before Tax36,110
Tax Provision-15,891
Net Income From Continuing Ops20,21920,219
Net Income19,727
Net Income Applicable To Common Shares19,727
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses1,324
Total Other Income/Expenses Net5,5959,152
 

Technicals of Core Laboratories NV

1. Trend Indicators

1.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Core Laboratories NV Daily Moving Averages ChartCore Laboratories NV Daily Moving Averages Chart
1.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Let's take a look of the Moving Average Convergence/Divergence (MACD) of Core Laboratories NV:

  • The Moving Average Convergence/Divergence (MACD) is 0.313. The Moving Average Convergence/Divergence (MACD) above zero is a bullish sign. +1
  • The MACD is lower than the signal line. This is a bearish indication. -1
Core Laboratories NV Daily Moving Average Convergence/Divergence (MACD) ChartCore Laboratories NV Daily Moving Average Convergence/Divergence (MACD) Chart
1.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index).

The ADX helps you determine the strength of a trend. Let's take a look of the ADX of Core Laboratories NV:

  • The ADX is 12.944. Not trending. -2
  • The ADX is declining, there is no upcoming trend indication. -1
  • The +DI is lower than the -DI. The current trend is down. -2
Core Laboratories NV Daily Directional Movement Index (DMI) ChartCore Laboratories NV Daily Directional Movement Index (DMI) Chart
1.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..
  • The Parabolic SAR is higher than the price. The current trend is down. -2
  • Core Laboratories NV Daily Parabolic SAR ChartCore Laboratories NV Daily Parabolic SAR Chart

    2. Momentum Indicators

    2.1 Relative Strength Index (RSI)

    Measures the speed and change of price movements.

    • Leading momentum indicator, meaning the signals are instant.
    • Ranges between 0 and 100.
    • Above 70 is considered overbought.
    • Below 30 is considered oversold.
    • Above or below 50 can also be used to determine price trend or support and resistance.
    • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
    • Can be used in many different ways
    • The RSI is above 50. +1
    Core Laboratories NV Daily Relative Strength Index (RSI) ChartCore Laboratories NV Daily Relative Strength Index (RSI) Chart
    2.2 Stochastic Oscillator

    Compares a certain price to multiple prices ranging over time.

    • Leading momentum indicator, meaning the signals are instant.
    • Used to determine overbought and oversold areas much like the RSI.
    • Ranges between 0 and 100.
    • Above 80 is considered overbought.
    • Below 20 is considered oversold.
    • Consists of two lines named K and D.
    • K compares the highest high and lowest low on the selected price range.
    • The D line is a moving average of the K line.
    • Can be used to spot divergences
    • The Stochastic is above 50. +1
    Core Laboratories NV Daily Stochastic Oscillator ChartCore Laboratories NV Daily Stochastic Oscillator Chart
    2.3 Commodity Channel Index (CCI)
    Core Laboratories NV Daily Commodity Channel Index (CCI) ChartCore Laboratories NV Daily Commodity Channel Index (CCI) Chart
    2.4 Chande Momentum Oscillator (CMO)
    Core Laboratories NV Daily Chande Momentum Oscillator (CMO) ChartCore Laboratories NV Daily Chande Momentum Oscillator (CMO) Chart
    2.5 Williams %R
    Core Laboratories NV Daily Williams %R ChartCore Laboratories NV Daily Williams %R Chart

    3. Volatility Indicators

    3.1 Bollinger Bands
    Core Laboratories NV Daily Bollinger Bands ChartCore Laboratories NV Daily Bollinger Bands Chart
    3.2 Average True Range (ATR)
    Core Laboratories NV Daily Average True Range (ATR) ChartCore Laboratories NV Daily Average True Range (ATR) Chart

    4. Volume Indicators

    4.1 On-Balance Volume (OBV)
    Core Laboratories NV Daily On-Balance Volume (OBV) ChartCore Laboratories NV Daily On-Balance Volume (OBV) Chart
    4.2 Money Flow Index (MFI)
    Core Laboratories NV Daily Money Flow Index (MFI) ChartCore Laboratories NV Daily Money Flow Index (MFI) Chart

    5. Summary

    5.1. Notifications

    TypeNotificationDate
    PenkeCurrently no notifications for Core Laboratories NV.

    5.2. Trading Signals

    DateIndicatorEntry signalExit signal
    2022-11-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
    ATR SHORT ENTRY LONG CLOSE
    2022-11-22STOCH LONG ENTRY SHORT CLOSE20 crossover to upside
    2022-11-24DMI SHORT ENTRY LONG CLOSE
    WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
    2022-11-25STOCH LONG ENTRY SHORT CLOSE20 crossover to upside
    2022-11-28DMI LONG ENTRY SHORT CLOSE
    WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
    2022-11-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

    5.2. Technical Score

    Let's check the technical score of Core Laboratories NV based on Penke's default Symbol scanner.

    Penke's Symbol Scanner

      
      
    IndicatorConditionValue
    RsiGreater than5056.173
    Ma 20Greater thanMa 5020.725
    Ma 50Greater thanMa 10018.787
    Ma 100Greater thanMa 20017.807
    OpenGreater thanClose20.500
    Total3/5 (60.0%)

    Comments

    Join the conversation.

    Leave a comment

    Stay informed about Core Laboratories NV.

    Receive notifications about Core Laboratories NV in your mailbox!

    Penke's Market Notifications
    AVVA.INDX
    5 minutes ago

    I found you a STOCH Bearish Hidden Divergence on the daily chart of AVVA.INDX.

    AVVA.INDX Daily Candlestick Chart
    DJU.INDX
    5 minutes ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of DJU.INDX.

    DJU.INDX Daily Candlestick Chart
    ADVN.INDX
    6 minutes ago

    I found you a MACD Bearish Reversal Divergence on the daily chart of ADVN.INDX.

    ADVN.INDX Daily Candlestick Chart
    SPFU.XETRA
    40 minutes ago

    I found you a Golden Cross on the daily chart of SPFU.XETRA.

    SPFU.XETRA Daily Candlestick Chart
    XMLC.XETRA
    46 minutes ago

    I found you a Golden Cross on the daily chart of XMLC.XETRA.

    XMLC.XETRA Daily Candlestick Chart
    JCHE.XETRA
    48 minutes ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of JCHE.XETRA.

    JCHE.XETRA Daily Candlestick Chart
    NK4L.XETRA
    48 minutes ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of NK4L.XETRA.

    NK4L.XETRA Daily Candlestick Chart
    METV.XETRA
    1 hour ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of METV.XETRA.

    METV.XETRA Daily Candlestick Chart
    KTN.XETRA
    1 hour ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of KTN.XETRA.

    KTN.XETRA Daily Candlestick Chart
    ECMS.XETRA
    1 hour ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of ECMS.XETRA.

    ECMS.XETRA Daily Candlestick Chart
    XDPU.XETRA
    1 hour ago

    I found you a Golden Cross on the daily chart of XDPU.XETRA.

    XDPU.XETRA Daily Candlestick Chart
    JCGA.LSE
    1 hour ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of JCGA.LSE.

    JCGA.LSE Daily Candlestick Chart
    JCAS.LSE
    1 hour ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of JCAS.LSE.

    JCAS.LSE Daily Candlestick Chart
    JCAP.LSE
    1 hour ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of JCAP.LSE.

    JCAP.LSE Daily Candlestick Chart
    SZU.XETRA
    1 hour ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of SZU.XETRA.

    SZU.XETRA Daily Candlestick Chart
    EQQD.LSE
    1 hour ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of EQQD.LSE.

    EQQD.LSE Daily Candlestick Chart
    H4ZN.XETRA
    1 hour ago

    I found you a Golden Cross on the daily chart of H4ZN.XETRA.

    H4ZN.XETRA Daily Candlestick Chart
    CBUN.XETRA
    1 hour ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of CBUN.XETRA.

    CBUN.XETRA Daily Candlestick Chart
    DRGG.LSE
    1 hour ago

    I found you a Oversold RSI (Relative Strength Index) on the daily chart of DRGG.LSE.

    DRGG.LSE Daily Candlestick Chart
    I500.XETRA
    1 hour ago

    I found you a Golden Cross on the daily chart of I500.XETRA.

    I500.XETRA Daily Candlestick Chart
    FUSR.XETRA
    1 hour ago

    I found you a Golden Cross on the daily chart of FUSR.XETRA.

    FUSR.XETRA Daily Candlestick Chart
    XNGI.XETRA
    1 hour ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of XNGI.XETRA.

    XNGI.XETRA Daily Candlestick Chart
    WELX.XETRA
    1 hour ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of WELX.XETRA.

    WELX.XETRA Daily Candlestick Chart
    V3YA.XETRA
    1 hour ago

    I found you a Golden Cross on the daily chart of V3YA.XETRA.

    V3YA.XETRA Daily Candlestick Chart
    FLRA.XETRA
    1 hour ago

    I found you a Overbought RSI (Relative Strength Index) on the daily chart of FLRA.XETRA.

    FLRA.XETRA Daily Candlestick Chart